Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cor360: Clinician-Facing Broad-Spectrum Cardiac Phenotyping and Risk Assessment Using COR® Wearable ECG to Inform Outcomes-Oriented Care Pathways

NCT07775976 is registered in ClinicalTrials.gov with Peerbridge Health, Inc as lead sponsor.

NCT NCT07775976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07775976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cor360: Clinician-Facing Broad-Spectrum Cardiac Phenotyping and Risk Assessment Using COR® Wearable ECG to Inform Outcomes-Oriented Care Pathways
Lead sponsor
Peerbridge Health, Inc
Phase
Observational
Overall status
Enrolling by invitation
Start date
August 20, 2026
Completion date
June 17, 2030
Enrollment
1,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmias, cardiac, atrial cardiomyopathy, bundle/fascicular abnormalities, cardiac arrest (ca), cardiac conduction system disease, cardiopulmonary, cardiovascular diseases, cardiovascular diseases risk, decision support systems, clinical, heart failure (for example, fluid overload), heart failure - nyha ii - iv, his-purkinje disease, hrv, myocardial ischemia, qt dispersion, rhythm phenotypes, seizure disorder, sleep apnea syndrome, obstructive, sudden cardiac arrest, syncope, syncope and collapse, syncope recurrent, ventricular arrhythmias and cardiac arrest, ventricular fibrillation